Pharmaceutical company Lupin has received tentative approval from the United States Food and Drug Administration to market its cholesterol lowering Pitavastatin tablets in the American market. has received approval for Pitavastatin tablets in the strength of 1 milligram, 2 mg and 4 mg. Pitavastatin is a generic version of Kowa's Livalo tablets in t
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Radmer, Bo, filed on February 23, 2015, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Novo Nordisk A/S. The following quote was obt
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Morrison, Mark Steven, filed on June 3, 2016, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Microdose Therapeutx, Inc.. The followi
ACCESSORIES AND MEDICAL MATERIALS, Injection capsules or needleless intravenous injection syringe equipment more info: Location: HONDURAS BidDate: 12/ 1/ 2016 Tender Country: HONDURAS Tender Type: Tenders Tendering Authority: Secretary of Public Health Tendering Authority Address: Address: OFFICE ADMINISTRATION HMCR ING.
According to news originating from Santiago, Chile, by NewsRx correspondents, research stated, "Solute transport across lipidic membranes is a fundamental process for both living organisms and drug delivery. Our news journalists obtained a quote from the research from the University of Santiago, "All these probes, independent of their localization
Innocoll, a global, commercial-stage, specialty pharmaceutical company, today announced that it has received a Refusal to File letter from the United States Food and Drug Administration for XARACOLL, the company s product candidate for the treatment of postsurgical pain. Upon preliminary review, the FDA determined that the application, which was
By a News Reporter-Staff News Editor at Drug Week SANOFI-AVENTIS DEUTSCHLAND GMBH has been issued patent number 9517311, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventor is Saiki, Masaru. This patent was filed on September 18, 2015 and was published online on December 13, 2016.
This week, Lupin received tentative approval for generic Giazo Tablets, Aurobindo Pharma got US FDA approval for 2 drugs and Glenmark Pharma gets USFDA approval for Tretinoin Capsules. Lupin receives tentative approval for generic Giazo Tablets Pharma Major Lupin Limited announced that it has received tentative approval for its Balasalazide Disodiu
Recent Findings in Drug Delivery Systems Described by Researchers from Department of Medicine. According to news reporting from New York City, New York, by NewsRx journalists, research stated, "Various nanodelivery systems have been designed to release therapeutic agents upon contact with specific enzymes. Distinguished Endowed Chair, US Department
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting originating from Jackson, Mississippi, by NewsRx correspondents, research stated, "Chemical analysis of small extracellular vesicles circulating in body fluids holds potentials in noninvasiv
Research Conducted at Chongqing University of Science and Technology Has Provided New Information about Drug Delivery Systems. Financial supporters for this research include National Natural Science Foundation of China, Natural Science Foundation Project of CQ, Chongqing Municipal Education Commission, National College Students' Scientific&...
By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. According to news reporting originating from Gif sur Yvette, France, by NewsRx correspondents, research stated, "Since both liposomes and nanoparticles have shown great potential in application for clinical di
By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Drug Delivery Systems is now available. According to news reporting originating from Aalborg, Denmark, by NewsRx correspondents, research stated, "This review presents the present-day literature on the anatomy and physiological mechanisms of the blood-brain barr
Study Findings on Drug Delivery Systems Are Outlined in Reports from University of Claude Bernard. According to news reporting originating in Lyon, France, by NewsRx journalists, research stated, "The blood-brain interfaces restrict the cerebral bioavailability of pharmacological compounds. The news reporters obtained a quote from the research from
Study Results from Institute of Chemistry in the Area of Drug Delivery Systems Reported. Funders for this research include National Basic Research Program of China, National key foundation for exploring scientific instrument, National Nature Science Foundation of China. The news reporters obtained a quote from the research from the Institute of...
"Global Drug Delivery Technologies- Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delive
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration relating to the company s new drug applications for oral an
CEMPRA, INC. (NASDAQ:CEMP) Files An 8-K Other Events Item8.01 Other Events. On December29, 2016, we issued a press release to report the receipt of a complete response letter from the U.S. Food and Drug Administration relating to our new drug applications for oral and intravenous solithromycin for the treatment of community-acquired bacterial pneum
Transparency Market Research Report Added "Implantable Drug Delivery Devices Market- Global Industry Analysis, Size, Share, Trends And Forecast 2016- 2024" Albany, NY 12/29/2016 Implantable Drug Delivery Devices Market: Overview. The global implantable drug delivery devices market is one of the fastest growing markets in the global medical de
Lupin's Balasalazide Disodium tablets 1.1 gm are the AB rated generic equivalent of Salix Pharmaceuticals Inc's Giazo Tablets, 1.1 gm.Pharma Major Lupin Limited announced today that it has received tentative approval for its Balasalazide Disodium Tablets, 1.1 gm from the United States Food and Drug Administration to market a generic version of Sali
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2016/ PRNewswire/ Mylan N.V., today announced the U.S. launch of Fosphenytoin Sodium Injection USP, 75 mg/mL,, packaged in 100 mg PE*/ 2 mL, and 500 mg PE*/ 10 mL single-use vials, a generic version of Pfizer's Cerebyx Injection. Fosphenytoin Sodium Injection USP, 75 mg/mL,, packaged in 100 mg PE
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2016/ PRNewswire/ Mylan N.V., today announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta Tablets. This launch also further strengthens our robust portfolio of central nervous system medicati
-Amphastar Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration issued a Complete Response Letter to its wholly-owned subsidiary, Armstrong Pharmaceuticals, Inc., for its New Drug Application for Primatene Mist. A CRL is a communication from the FDA that informs companies that an application cannot be approved in its pr
Release date- 23122016- Mumbai- Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, has yielded a final approval for its lead MDI product Fluticasone+ Salmeterol from UK MHRA for its partner in the UK. Cipla's Sereflo will be launched in the UK through a partner in
This report studies Drug Delivery Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.. Browse Full Report Visit- http://www.acutemarketreports.com/report/drug-delivery-devices-market.